Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio (2009 - 2026)
Vertex Pharmaceuticals' (VRTX) quarterly Interest Coverage Ratio came in at 2.71 in Q1 2026, up 53.59% year-on-year from 1.76 in Q1 2025, and down 99.12% quarter-over-quarter from 309.21 in Q4 2025.
Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals' Interest Coverage Ratio history runs 18 years deep, the most recent figure standing at 2.71 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 53.59% year-over-year to 2.71 in Q1 2026; TTM through Mar 2026 was 11.14, a 636.27% increase from a year earlier, with the FY2025 full-year figure at 9.56, up 1501.17% from the prior year.
- Interest Coverage Ratio retreated to 2.71 in Q1 2026 per VRTX's latest filing, from 309.21 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 309.21 in Q4 2025 and bottomed at 11.36 in Q2 2024.
- The 5-year median for Interest Coverage Ratio is 4.1 (2023), against an average of 32.02.
- Across the five-year window, Interest Coverage Ratio slumped 377.22% in 2024 and surged 2482.74% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 92.28 in 2022, then gained by 1.06% to 93.25 in 2023, then sank by 87.16% to 11.97 in 2024, then jumped by 2482.74% to 309.21 in 2025, then slumped by 99.12% to 2.71 in 2026.
- Per Business Quant, the three latest VRTX Interest Coverage Ratio figures stand at 2.71 (Q1 2026), 309.21 (Q4 2025), and 2.81 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 3.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.71 |
| Dec 31, 2025 | 309.21 |
| Sep 30, 2025 | 2.81 |
| Jun 30, 2025 | 2.79 |
| Mar 31, 2025 | 1.76 |
| Dec 31, 2024 | 11.97 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | -11.36 |
| Mar 31, 2024 | 3.78 |
| Dec 31, 2023 | 93.25 |
| Sep 30, 2023 | 4.23 |
| Jun 30, 2023 | 4.10 |
| Mar 31, 2023 | 3.35 |
| Dec 31, 2022 | 92.28 |
| Sep 30, 2022 | 7.78 |
| Jun 30, 2022 | 7.62 |
| Mar 31, 2022 | 7.58 |
| Dec 31, 2021 | -68.57 |
| Sep 30, 2021 | 11.85 |
| Jun 30, 2021 | -0.45 |